Gemzar and thrombocytopenia Patient Reports February 13, 2012

Gemzar Side Effects Report #5898199-3
Gemzar side effect was reported by a Physician from FRANCE on Sept 15, 2008. Male patient, 66 years of age, weighting 178.6 lb, was diagnosed with transitional cell carcinoma, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute hepatic failure, cholecystitis, inflammation, microcytic anaemia, renal failure acute, retrograde portal vein flow, thrombocytopenia, venoocclusive liver disease. Gemzar dosage: 1000MG/M2 (2000 MG/M2 INFUSION), DAI AND DAY 8 OF A 21 DAY CYCLE. During the same period patient was treated with ELOXATIN, NEXIUM, THERALENE, DEFIBROTIDE, TRANXENE, VOGALENE, ZOPHREN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #6034235-1
Gemzar side effect was reported by a Physician from FRANCE on Jan 05, 2009. Male patient, 66 years of age, weighting 178.6 lb, was diagnosed with transitional cell carcinoma, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute hepatic failure, cholecystitis, hepatic fibrosis, inflammation, microcytic anaemia, renal failure acute, retrograde portal vein flow, thrombocytopenia. Gemzar dosage: 1000MG/M2 (2000 MG/M2 INFUSION), DAI AND DAY 8 OF A 21 DAY CYCLE. During the same period patient was treated with ELOXATIN, NEXIUM, TRANXENE, VOGALENE, ZOPHREN, PERIDYS, DEFIBROTIDE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #6097828-1
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Female patient, 50 years of age, was diagnosed with synovial sarcoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, cholecystitis infective, disease progression, microangiopathic haemolytic anaemia, nephropathy toxic, petechiae, renal failure, thrombocytopenia. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5984012-2
Gemzar side effect was reported by a Physician from FRANCE on Nov 26, 2008. Male patient, 60 years of age, was diagnosed with squamous cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholestasis, condition aggravated, cytolytic hepatitis, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with PLATINUM COMPOUNDS. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5485616-6
Gemzar side effect was reported by a Physician from FRANCE on Oct 05, 2007. Female patient, 56 years of age, was diagnosed with squamous cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: eyelid oedema, oedema peripheral, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5486385-6
Gemzar side effect was reported by a Physician from FRANCE on Oct 05, 2007. Female patient, 56 years of age, was diagnosed with squamous cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: eyelid oedema, oedema peripheral, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5130119-1
Gemzar side effect was reported by a Health Professional from JAPAN on Sept 29, 2006. Male patient, 53 years of age, was diagnosed with prostate cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone lesion, malignant neoplasm progression, neutropenia, thrombocytopenia. Gemzar dosage: 1000 MG/M2, INTRAVENOUS ; INTRAVENOUS. During the same period patient was treated with DOCETAXEL, CARBOPLATIN. Patient died on 07/01/2003.

Gemzar Side Effects Report #5130122-1
Gemzar side effect was reported by a Health Professional from JAPAN on Sept 29, 2006. Male patient, 69 years of age, was diagnosed with prostate cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: hepatitis acute, herpes zoster, muscular weakness, neutropenia, thrombocytopenia. Gemzar dosage: 800 MG/M2 INTRAVENOUS. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, THERAPEUTIC RADIOPHARMACEUTICALS. Patient died on 08/01/2003.

Gemzar Side Effects Report #5836630-X
Gemzar side effect was reported by a Physician from JAPAN on July 28, 2008. Male patient, weighting 103.8 lb, was diagnosed with pleural mesothelioma malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, lymphangiosis carcinomatosa, malignant neoplasm progression, pericarditis, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, HUMALOG, ADALAT, OMEPRAZOLE, NITROL, MAGMITT, LOXONIN, SELBEX. Patient died on 06/13/2008.


Gemzar Side Effects Report #5496454-2
Gemzar side effect was reported by a Physician from GERMANY on Oct 12, 2007. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure acute, pulmonary oedema, thrombocytopenia. Gemzar dosage: 800 MG/M2, DAY 1,8 AND 15 EVERY 28 DAYS. During the same period patient was treated with MITOMYCIN. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #5694491-6
Gemzar side effect was reported by a Physician from FRANCE on Mar 26, 2008. Female patient, 62 years of age, weighting 112.4 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: hypoalbuminaemia, malnutrition, thrombocytopenia. Gemzar dosage: 500 MG/M2, OTHER. Patient recovered.

Gemzar Side Effects Report #5591949-5
Gemzar side effect was reported by a Physician from FRANCE on Jan 04, 2008. Female patient was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, haemolytic uraemic syndrome, left ventricular failure, thrombocytopenia. Gemzar dosage: 1800 MG, WEEKLY (1/W). During the same period patient was treated with EUPANTOL, LASIX, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5102742-1
Gemzar side effect was reported by a Pharmacist from GERMANY on Aug 22, 2006. Female patient, 76 years of age, weighting 121.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood creatinine increased, capillary leak syndrome, hypokalaemia, hypoproteinaemia, pleural effusion, thrombocytopenia. Gemzar dosage: 1999 MG/M2, DAILY (1/D); INTRAVENOUS. During the same period patient was treated with KEVATRIL, NEXIUM, FUROSEMIDE, VALORON, NOVALGIN, PASPERTIN, EMBOLEX. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4992759-X
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 17, 2005. Male patient, 72 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, nausea , thrombocytopenia. Gemzar dosage: 1000 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5030746-6
Gemzar side effect was reported by a Pharmacist from FRANCE on June 02, 2006. Male patient, 71 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic anaemia, haemolytic uraemic syndrome, hypertension, renal failure, splenic infarction, thrombocytopenia. Gemzar dosage: 1000 MG/M2, WEEKLY (1/W), INTRAVENOUS. During the same period patient was treated with PLITICAN, DELURSAN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5322144-2
Gemzar side effect was reported by a Physician from GERMANY on May 08, 2007. Female patient, 70 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, pulmonary fibrosis , thrombocytopenia, urinary tract infection . Gemzar dosage: unknown. During the same period patient was treated with THYROID HORMONES, VERGENTAN, MORPHINE, TRIARESE. Patient recovered.

Gemzar Side Effects Report #4900638-9
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 19, 2006. Male patient, 70 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocytopenia, visual acuity reduced. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA. Patient recovered.

Gemzar Side Effects Report #5447730-0
Gemzar side effect was reported by a Physician from FRANCE on Sept 03, 2007. Male patient, 69 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gingival bleeding, thrombocytopenia, tongue haematoma. Gemzar dosage: 1960 MG, OTHER. During the same period patient was treated with ELOXATIN, ONDANSETRON. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5579333-1
Gemzar side effect was reported by a Physician from JAPAN on Dec 19, 2007. Male patient, 68 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, diabetes mellitus, malignant neoplasm progression, thrombocytopenia, white blood cell count decreased. Gemzar dosage: 1000 MG, WEEKLY(1/W). During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5239772-5
Gemzar side effect was reported by a Physician from FRANCE on Feb 06, 2007. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: coma hepatic, hepatitis cholestatic, hiccups, leukocytosis, thrombocytopenia. Gemzar dosage: 1600 MG, OTHER. During the same period patient was treated with ELOXATIN. Patient was hospitalized. Patient died on 09/14/2006.

Gemzar Side Effects Report #5706567-5
Gemzar side effect was reported by a Physician from FRANCE on Apr 03, 2008. Male patient, 56 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholecystitis, disseminated intravascular coagulation, interstitial lung disease, thrombocytopenia. Gemzar dosage: 1970 MG, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5796161-2
Gemzar side effect was reported by a Physician from FRANCE on June 17, 2008. Male patient, 56 years of age, weighting 156.5 lb, was diagnosed with pancreatic carcinoma, escherichia bacteraemia, depression , pain  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholecystitis, disseminated intravascular coagulation, dyspnoea, interstitial lung disease, thrombocytopenia. Gemzar dosage: 1970 MG, ON DAY 1, 8 AND 15 OF 4 WEEKLY CYCLES. During the same period patient was treated with CLAMOXYL, SEROPLEX, SKENAN, OFLOCET. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5113191-4
Gemzar side effect was reported by a Physician from UNITED STATES on Sept 01, 2006. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocytopenia. Gemzar dosage: unknown. Patient died.

Gemzar Side Effects Report #5778095-2
Gemzar side effect was reported by a Physician from GERMANY on June 09, 2008. Female patient, weighting 158.7 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, thrombocytopenia. Gemzar dosage: 1500 MG, WEEKLY (1/W). During the same period patient was treated with TARCEVA. Patient recovered.


Gemzar Side Effects Report #5889494-2
Gemzar side effect was reported by a Physician from DENMARK on Sept 08, 2008. Male patient, weighting 220.5 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood creatine increased, blood urea increased, dyspnoea, nephropathy, oedema peripheral, thrombocytopenia. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #6039121-9
Gemzar side effect was reported by a Physician from FRANCE on Jan 09, 2009. Male patient, weighting 123.5 lb, was diagnosed with pancreatic carcinoma, thrombophlebitis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: hypoglycaemia, international normalised ratio increased, thrombocytopenia, thrombophlebitis. Gemzar dosage: 1000 MG/M2, WEEKLY, FOR 7 WEEKS FOLLOWED BY 1 WEEK REST. During the same period patient was treated with CALCIPARINE, PREVISCAN, ORGARAN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5706547-X
Gemzar side effect was reported by a Physician from GREECE on Apr 03, 2008. Female patient was diagnosed with ovarian epithelial cancer, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocytopenia. Gemzar dosage: 1500 MG/M2 AS 30 MIN INFUSION, ON DAYS 1 AND 8 EVERY 21 DAYS. During the same period patient was treated with ELOXATIN, ONDANSETRON, DEXAMETHASONE, DIAZEPAM. Patient died.

Gemzar Side Effects Report #6027222-0
Gemzar side effect was reported by a Physician from GREECE on Dec 29, 2008. Female patient was diagnosed with ovarian epithelial cancer, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocytopenia. Gemzar dosage: 1500 MG/M2 AS 30 MIN INFUSION, ON DAYS 1 AND 8 EVERY 21 DAYS. During the same period patient was treated with ELOXATIN, ONDANSETRON, DEXAMETHASONE, DIAZEPAM. Patient died.

Gemzar Side Effects Report #6079362-8
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 13, 2009. Female patient, 52 years of age, was diagnosed with ovarian cancer recurrent, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebrovascular accident, disease progression, hypercalcaemia, international normalised ratio increased, metastases to bone, spinal cord compression, thrombocytopenia. Gemzar dosage: 1000 MG/M2, DAYS 1 AND 15. During the same period patient was treated with CISPLATIN, BEVACIZUMAB, ZOFRAN, DEXAMETHASONE, LORAZEPAM, METOCLOPRAMIDE, ATIVAN. Patient was hospitalized. Patient died.


Gemzar Side Effects Report #6119241-0
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2009. Female patient, 51 years of age, was diagnosed with ovarian cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: coagulopathy, thrombocytopenia, thrombotic thrombocytopenic purpura. Gemzar dosage: 800 MG/M2, UNK. During the same period patient was treated with CARBOPLATIN. Patient died.

Gemzar Side Effects Report #4844620-9
Gemzar side effect was reported by a Pharmacist from UNITED STATES on Nov 30, 2005. Female patient, 55 years of age, weighting 120.0 lb, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: neuropathy peripheral, skin discolouration, thrombocytopenia, vasculitis . Gemzar dosage: 1500 MG Q 3 WK OUT OF 4 WKS. During the same period patient was treated with ARANESP. Patient recovered.

Gemzar Side Effects Report #4806644-7
Gemzar side effect was reported by a Physician from UNITED STATES on Oct 03, 2005. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: myalgia, thrombocytopenia. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CARBOPLATIN. Patient died.

Gemzar Side Effects Report #4821682-6
Gemzar side effect was reported by a Physician from UNITED STATES on Oct 14, 2005. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: myalgia, sepsis , thrombocytopenia, urinary tract infection . Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died on 10/03/2005.

Gemzar Side Effects Report #4990424-6
Gemzar side effect was reported by a Health Professional from UNITED STATES on Mar 29, 2005. Male patient, 79 years of age, weighting 219.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, dizziness , neutropenia, thrombocytopenia. Gemzar dosage: 1780 MG, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, FLECAINIDE ACETATE, LIPITOR, FLONASE, SINEMET CR, VITAMIN C. Patient recovered.


Gemzar Side Effects Report #5062511-8
Gemzar side effect was reported by a Physician from FRANCE on July 05, 2006. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocythaemia, thrombocytopenia. Gemzar dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #4992722-9
Gemzar side effect was reported by a Health Professional from UNITED STATES on Aug 11, 2005. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: pneumonitis, renal failure acute, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, GLUCOPHAGE, LISINOPRIL, ADVAIR DISKUS, ASPIRIN, NEUPOGEN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4882930-X
Gemzar side effect was reported by a Physician from GERMANY on Jan 06, 2006. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: leukopenia, peripheral arterial occlusive disease, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, BETA BLOCKING AGENTS, ACE INHIBITOR NOS, INSULIN, SELENIUM. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4607270-5
Gemzar side effect was reported by a Physician from on Feb 18, 2005. Male patient, 63 years of age, weighting 244.7 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: agranulocytosis, dialysis , renal failure, thrombocytopenia. Gemzar dosage: 2800 MG OTHER. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 01/01/2005.

Gemzar Side Effects Report #4579479-0
Gemzar side effect was reported by a Physician from on Jan 25, 2005. Male patient, 62 years of age, weighting 244.7 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: agranulocytosis, dialysis , renal failure, thrombocytopenia. Gemzar dosage: 2800 MG OTHER. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #4588311-0
Gemzar side effect was reported by a Physician from on Feb 02, 2005. Male patient, 62 years of age, weighting 244.7 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: agranulocytosis, dialysis , renal failure, thrombocytopenia. Gemzar dosage: 2800 MG OTHER. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4870678-7
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Dec 08, 2005. Male patient, 61 years of age, weighting 202.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, thrombocytopenia. Gemzar dosage: 2400 MG, INTRAVENOUS : 1900 MG, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, ATENOLOL, SIMVASTATIN, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5653643-1
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on Feb 26, 2008. Female patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, colitis ulcerative, rectal haemorrhage, thrombocytopenia. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4937246-X
Gemzar side effect was reported by a Pharmacist from FRANCE on Feb 17, 2006. Male patient, 57 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, neuropathy peripheral, septic shock, thrombocytopenia. Gemzar dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with ALIMTA, CISPLATIN, TAXOL, FOLIC ACID, VITAMIN B12, CORTICOSTEROID NOS, NEULASTA, TRAMADOL. Patient was hospitalized. Patient died on 09/23/2005.

Gemzar Side Effects Report #5164700-0
Gemzar side effect was reported by a Physician from FRANCE on Nov 27, 2006. Male patient, 55 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: neutropenia, septic shock, thrombocytopenia. Gemzar dosage: unknown. Patient was hospitalized. Patient died on 11/01/2006.

Gemzar Side Effects Report #4970861-6
Gemzar side effect was reported by a Health Professional from FRANCE on Mar 27, 2006. Male patient, 52 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, haemolytic uraemic syndrome, international normalised ratio increased, peripheral ischaemia, thrombocytopenia. Gemzar dosage: 1250 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, THERAPEUTIC RADIOPHARMACEUTICALS, PREVISCAN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4741617-4
Gemzar side effect was reported by a Pharmacist from FRANCE on July 25, 2005. Female patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: angioneurotic oedema, face oedema, fear, refusal of treatment by patient, respiratory disorder, superior vena caval occlusion, thrombocytopenia. Gemzar dosage: 1250 MG/M2/2 OTHER. During the same period patient was treated with CARBOPLATIN, ZOMETA, INNOHEP. Patient recovered.

Gemzar Side Effects Report #4806754-4
Gemzar side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on July 07, 2005. Female patient, 50 years of age, weighting 119.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, dyspnoea, thrombocytopenia. Gemzar dosage: 450 MG/6. During the same period patient was treated with OXYCONTIN, ANZEMET, MACPERAN, MEGACE. Patient recovered.

Gemzar Side Effects Report #5068002-2
Gemzar side effect was reported by a Health Professional from UNITED KINGDOM on July 12, 2006. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: epistaxis, melaena, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5088949-0
Gemzar side effect was reported by a Health Professional from UNITED KINGDOM on Aug 03, 2006. Female patient, 49 years of age, weighting 159.2 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: epistaxis, melaena, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, CODEINE. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #4807059-8
Gemzar side effect was reported by a Physician from KOREA, REPUBLIC OF on July 07, 2005. Female patient, 44 years of age, weighting 110.2 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: granulocytopenia, syncope, thrombocytopenia. Gemzar dosage: 1560 MG OTHER. During the same period patient was treated with GRANISETRON, DEXAMETHASONE. Patient recovered.

Gemzar Side Effects Report #4848076-1
Gemzar side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 16, 2005. Female patient, 44 years of age, weighting 110.9 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, asthenia, disease progression, fatigue, granulocytopenia, syncope, thrombocytopenia. Gemzar dosage: 1560 MG, OTHER, INTRAVENOUS. During the same period patient was treated with GRANISETRON, DEXAMETHASONE. Patient recovered.

Gemzar Side Effects Report #5675315-X
Gemzar side effect was reported by a Physician from UNITED STATES on Aug 14, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, COUMADIN. Patient recovered.

Gemzar Side Effects Report #5675388-4
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 14, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocytopenia. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #5142793-4
Gemzar side effect was reported by a Pharmacist from UNITED STATES on Oct 13, 2006. Male patient, 64 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, DEXAMETHASONE. Patient recovered.

Gemzar Side Effects Report #6114852-0
Gemzar side effect was reported by a Health Professional from UNITED STATES on Apr 11, 2008. Female patient, 80 years of age, weighting 168.0 lb, was diagnosed with neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: neutropenia, thrombocytopenia. Gemzar dosage: 1800 MG, OTHER. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #5520479-1
Gemzar side effect was reported by a Physician from FRANCE on Nov 08, 2007. Female patient, 74 years of age, was diagnosed with neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, neutropenia, sepsis , thrombocytopenia. Gemzar dosage: 1250 MG/M2, DAILY (1/D). During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #4746422-0
Gemzar side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 16, 2005. Female patient, weighting 188.7 lb, was diagnosed with neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Gemzar dosage: 1000 MG , IV Q 3 WKS DAY 1 AND DAY 8. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5989269-X
Gemzar side effect was reported by a Physician from FRANCE on Dec 04, 2008. Female patient, 74 years of age, was diagnosed with metastatic carcinoma of the bladder and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, neutropenia, neutropenic sepsis, thrombocytopenia. Gemzar dosage: 1250 MG/M2, DAILY (1/D). During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died on 01/01/2006.

Gemzar Side Effects Report #5227406-5
Gemzar side effect was reported by a Physician from GERMANY on Jan 24, 2007. Male patient, 67 years of age, was diagnosed with metastasis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow failure, cardiac arrest , coronary artery disease , myocardial infarction, thrombocytopenia, thrombosis in device. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, CLOPIDOGREL, ASPIRIN. Patient was hospitalized. Patient died.


Gemzar Side Effects Report #4608760-1
Gemzar side effect was reported by a Physician from on Feb 18, 2005. Female patient, 66 years of age, weighting 75.00 lb, was diagnosed with metastases to central nervous system and was treated with Gemzar. After drug was administered, patient experienced the following side effects: neutropenia, thrombocytopenia, urinary tract infection staphylococcal. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, COUMADIN, IMOVANE, SERETIDE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4639984-5
Gemzar side effect was reported by a Physician from on Mar 30, 2005. Female patient, 79 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, c-reactive protein increased, febrile neutropenia, gastrointestinal haemorrhage, haemoglobin decreased, thrombocytopenia, white blood cell agglutination present. Gemzar dosage: 1350 MG. During the same period patient was treated with CARBOPLATIN, THYROXINE, ZYRTEC, DETRUSITOL, ALBYL, ZOCOR. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4642054-3
Gemzar side effect was reported by a Physician from on Mar 30, 2005. Female patient, 79 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, c-reactive protein increased, febrile neutropenia, gastric ulcer, gastrointestinal haemorrhage, haemoglobin decreased, thrombocytopenia, white blood cell agglutination present. Gemzar dosage: 1350 MG OTHER. During the same period patient was treated with CARBOPLATIN, THYROXINE, ZYRTEC, DETRUSITOL, ALBYL, ZOCOR. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4928135-5
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on Feb 01, 2006. Female patient, 55 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow failure, thrombocytopenia. Gemzar dosage: unknown. Patient died on 09/22/2005.

Gemzar Side Effects Report #4939451-5
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on Feb 27, 2006. Male patient, 47 years of age, weighting 123.5 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, RETROVIR, LOVENOX. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5531956-1
Gemzar side effect was reported by a Physician from FRANCE on Nov 23, 2007. Male patient was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, dysphagia, dyspnoea, face oedema, localised oedema, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, DEPAKINE CHRONO, TANAKAN, LEVOTHYROX. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4947491-5
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on Feb 27, 2006. Female patient, 65 years of age, was diagnosed with lung neoplasm and was treated with Gemzar. After drug was administered, patient experienced the following side effects: neutropenia, purpura, pyrexia, thrombocytopenia, toxic skin eruption, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4883917-3
Gemzar side effect was reported by a Physician from FRANCE on Jan 03, 2006. Female patient, 63 years of age, was diagnosed with lung adenocarcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic anaemia, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN, PREDNISOLONE. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #5263907-1
Gemzar side effect was reported by a Physician from FRANCE on Mar 07, 2007. Male patient, 67 years of age, weighting 154.3 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, angiodysplasia, gastrointestinal haemorrhage, rectal haemorrhage, thrombocytopenia. Gemzar dosage: 1824 MG, OTHER. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4546650-3
Gemzar side effect was reported by a Physician from on Dec 16, 2004. Male patient, 60 years of age, weighting 165.3 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: adenocarcinoma, bone marrow depression, haemoglobin decreased, malignant neoplasm progression, nausea , pain , thrombocytopenia, white blood cell count increased. Gemzar dosage: 2410 MG/2 OTHER. During the same period patient was treated with CARBOPLATIN, MORPHINE, LANSOPRAZOLE, CORDARONE, FLUCONAZOLE. Patient was hospitalized. Patient died on 11/14/2004.


Gemzar Side Effects Report #4964502-1
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on Mar 21, 2006. Male patient, 59 years of age, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: neutropenia, purpura, rash erythematous, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, NEULASTA, ZOFRAN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5117716-4
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on Sept 06, 2006. Male patient, 55 years of age, weighting 165.3 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, circulatory collapse, hyperkalaemia, hyponatraemia, myositis , renal failure acute, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, CARBOPLATIN, NEORAL, CORTANCYL, BACTRIM DS, VALACYCLOVIR, FLUCONAZOLE, CACIT D. Patient was hospitalized. Patient died on 07/08/2006.

Gemzar Side Effects Report #5149770-8
Gemzar side effect was reported by a Physician from BRAZIL on Oct 31, 2006. Female patient, 53 years of age, was diagnosed with lung adenocarcinoma, metastases to bone, hypertension and was treated with Gemzar. After drug was administered, patient experienced the following side effects: coagulopathy, dengue fever, hypovolaemic shock, leukopenia, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, ZOMETA, ENALAPRIL MALEATE. Patient died.

Gemzar Side Effects Report #4936725-9
Gemzar side effect was reported by a Physician from GERMANY on Feb 15, 2006. Female patient, child 12 years of age, was diagnosed with leukaemia recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, thrombocytopenia. Gemzar dosage: 1200 MG/M2, OTHER, INTRAVENOUS. Patient died.

Gemzar Side Effects Report #4950021-5
Gemzar side effect was reported by a Physician from GERMANY on Mar 02, 2006. Female patient, child 12 years of age, was diagnosed with leukaemia recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease recurrence, gastrointestinal haemorrhage, thrombocytopenia. Gemzar dosage: 1200 MG/M2, OTHER, INTRAVENOUS. Patient died.

Gemzar Side Effects Report #5166869-0
Gemzar side effect was reported by a Physician from BRAZIL on Nov 28, 2006. Male patient, 25 years of age, was diagnosed with germ cell cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: epistaxis, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5712581-6
Gemzar side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient was diagnosed with gallbladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, thrombocytopenia. Gemzar dosage: 1400 MG, OTHER. Patient died on 01/01/2008.

Gemzar Side Effects Report #5278048-7
Gemzar side effect was reported by a Physician from BRAZIL on Mar 08, 2007. Male patient, 25 years of age, weighting 183.0 lb, was diagnosed with extragonadal primary germ cell cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: epistaxis, thrombocytopenia. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with OXALIPLATIN, KYTRIL, ANTAK, DEXAMETHASONE, MAGNESIUM SULPHATE, GLUCONATO DE CALCIO. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5948225-8
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Oct 29, 2008. Male patient, 31 years of age, was diagnosed with burkitt's lymphoma, acute lymphocytic leukaemia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow failure, neutropenia, pneumonia , stenotrophomonas infection, thrombocytopenia. Gemzar dosage: 3600 MG/M2, PER DOSE INFUSION OVER 6 HOURS ON DAY 7 (CYCLE ONE). During the same period patient was treated with TOPOTECAN, VINORELBINE, THIOTEPA, DEXAMETHASONE, NEUPOGEN. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #5263922-8
Gemzar side effect was reported by a Physician from ITALY on Feb 26, 2007. Female patient, 76 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia, transient ischaemic attack. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient recovered.


Gemzar Side Effects Report #5263917-4
Gemzar side effect was reported by a Physician from ITALY on Feb 26, 2007. Female patient, 72 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, constipation , deafness, thrombocytopenia. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient died.

Gemzar Side Effects Report #5449101-X
Gemzar side effect was reported by a Physician from ITALY on Sept 07, 2007. Female patient, 72 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, constipation , deafness, thrombocytopenia. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient died.

Gemzar Side Effects Report #5452786-5
Gemzar side effect was reported by a Physician from ITALY on Sept 07, 2007. Female patient, 72 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: asthenia, constipation , deafness, thrombocytopenia. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with VINORELBINE. Patient died.

Gemzar Side Effects Report #4638161-1
Gemzar side effect was reported by a Physician from on Mar 24, 2005. Female patient, 56 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, granulocyte count decreased, haemolytic anaemia, red blood cell schistocytes present, thrombocytopenia, thrombotic thrombocytopenic purpura, white blood cell count decreased. Gemzar dosage: 2670 MG. During the same period patient was treated with CALCIUM GLUCONATE, COUMADIN, OMEGA, AMBIEN, PROTONIX, FLEXERIL, LEXAPRO. Patient recovered.

Gemzar Side Effects Report #4588048-8
Gemzar side effect was reported by a Physician from on Jan 31, 2005. Female patient, 52 years of age, weighting 121.3 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, eyelid oedema, face oedema, oedema peripheral, pruritus, rash scarlatiniform, thrombocytopenia. Gemzar dosage: 1000 MG/M2/2 OTHER. During the same period patient was treated with TAXOL, CORTICOSTEROID NOS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4642053-1
Gemzar side effect was reported by a Physician from on Mar 31, 2005. Female patient, 52 years of age, weighting 121.3 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, eyelid oedema, face oedema, oedema peripheral, rash pruritic, rash scarlatiniform, thrombocytopenia. Gemzar dosage: 1000 MG/M2/2 OTHER. During the same period patient was treated with TAXOL, KYTRIL, RANITIDINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4611097-8
Gemzar side effect was reported by a Health Professional from on Mar 16, 2005. Female patient, 45 years of age, weighting 152.0 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, nausea , thrombocytopenia. Gemzar dosage: 1375 MG IV Q WKS. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4992783-7
Gemzar side effect was reported by a Health Professional from UNITED STATES on Apr 01, 2005. Female patient, 45 years of age, weighting 152.3 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, nausea , thrombocytopenia. Gemzar dosage: 1375 MG, INTRAVENOUS. During the same period patient was treated with TAXOTERE, COUMADIN, PHENERGAN, ANZEMET, DECADRON. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5241740-4
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 14, 2007. Male patient, 60 years of age, was diagnosed with bladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, scleroderma , sepsis , thrombocytopenia, vasculitis necrotising. Gemzar dosage: 2000 MG, OTHER. During the same period patient was treated with CISPLATIN, TAXOL, CARBOPLATIN. Patient died on 02/01/2007.

Gemzar Side Effects Report #5241752-0
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 12, 2007. Male patient, 60 years of age, was diagnosed with bladder cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, scleroderma , sepsis , thrombocytopenia, vasculitis necrotising. Gemzar dosage: 2000 MG, OTHER. During the same period patient was treated with CISPLATIN. Patient died on 02/01/2007.

Gemzar Side Effects Report #5675429-4
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 22, 2007. Male patient, 83 years of age, was diagnosed with bladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocytopenia. Gemzar dosage: 1000 MG. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #5675430-0
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 22, 2007. Male patient, 78 years of age, was diagnosed with bladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: thrombocytopenia, white blood cell count decreased. Gemzar dosage: 1000 MG, INTRAVENOUS. Patient recovered.

Gemzar Side Effects Report #4765134-0
Gemzar side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2005. Male patient, 74 years of age, weighting 266.8 lb, was diagnosed with bladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: arthralgia, deep vein thrombosis , joint swelling, pulmonary embolism , thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #4765133-9
Gemzar side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2005. Male patient, 73 years of age, weighting 121.3 lb, was diagnosed with bladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: deep vein thrombosis , pain in extremity, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient recovered.

Gemzar Side Effects Report #5208809-1
Gemzar side effect was reported by a Physician from GERMANY on Jan 08, 2007. Female patient, 71 years of age, was diagnosed with bladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: deep vein thrombosis , influenza like illness, leukopenia, thrombocytopenia, vasculitis necrotising. Gemzar dosage: 1500 MG, UNK. During the same period patient was treated with CISPLATIN, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5253419-3
Gemzar side effect was reported by a Physician from GERMANY on Feb 22, 2007. Female patient, 71 years of age, was diagnosed with bladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, catheter related complication, catheter related infection, deep vein thrombosis , influenza like illness, leukopenia, peripheral arterial occlusive disease, thrombocytopenia, urological examination abnormal. Gemzar dosage: 1500 MG, UNK. During the same period patient was treated with CISPLATIN, CARBOPLATIN, OMNISCAN, AMPICILLIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5303227-X
Gemzar side effect was reported by a Physician from FRANCE on Apr 17, 2007. Male patient, 58 years of age, weighting 238.1 lb, was diagnosed with bladder cancer , hypertension, diabetes mellitus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: hypertension, malignant neoplasm progression, microangiopathy, renal failure, thrombocytopenia. Gemzar dosage: 2000 MG, OTHER. During the same period patient was treated with CISPLATIN, CARBOPLATIN, ATENOLOL, TRIATEC, INSULIN. Patient recovered.

Gemzar Side Effects Report #6077717-9
Gemzar side effect was reported by a Physician from FRANCE on Feb 06, 2009. Male patient, 58 years of age, weighting 238.1 lb, was diagnosed with bladder cancer , hypertension, diabetes mellitus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: hypertension, malignant neoplasm progression, renal failure, retinopathy, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, CARBOPLATIN, ATENOLOL, TRIATEC, INSULIN. Patient died on 01/01/2007.

Gemzar Side Effects Report #4684775-2
Gemzar side effect was reported by a Health Professional from on Apr 14, 2005. Male patient, 54 years of age, was diagnosed with bladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemolytic anaemia, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with ALIMTA. Patient recovered.

Gemzar Side Effects Report #6070188-8
Gemzar side effect was reported by a Physician from FRANCE on Feb 03, 2009. Male patient was diagnosed with bladder cancer , nausea , hyperkalaemia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, myoglobinaemia, nausea , nutritional condition abnormal, renal failure acute, rhabdomyolysis, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, LYRICA, EMEND, SKENAN, IMOVANE, HAEMODIALYTICS AND HAEMOFILTRATES. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5273938-3
Gemzar side effect was reported by a Physician from FRANCE on Mar 16, 2007. Male patient, 56 years of age, weighting 158.7 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, confusional state, fall , jaundice , pyrexia, subdural haemorrhage, thrombocytopenia, white blood cell count increased. Gemzar dosage: unknown. During the same period patient was treated with LASIX, ZOPHREN, DELURSAN, NEURONTIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5286557-X
Gemzar side effect was reported by a Physician from FRANCE on Mar 27, 2007. Male patient, 56 years of age, weighting 158.7 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, confusional state, fall , jaundice , pyrexia, subdural haemorrhage, thrombocytopenia, white blood cell count increased. Gemzar dosage: 1800 MG, OTHER. During the same period patient was treated with LASIX, ZOPHREN, DELURSAN, NEURONTIN. Patient was hospitalized. Patient recovered.